corporate powerpoint template · 12. 1,018 1,016 984 798 600 650 700 750 800 850 900 950 1000 1050...
TRANSCRIPT
CIBENZA® EP150
Practical application of Cibenza in
feed. Some examples
2
allows
to formulate your poultry feeds cheaperwhile maintaining diet performance
Mode of action
- Protein digestibility
- Gut flora modulation
4
Poultry: digestibility study
procedures
• Ross 308 chicks
• Ad libitum access to feed
• Common diet from hatch to d 15 of age
• Test diets were fed from 16 to 21 d of age
• At day 21, chicks were euthanized to collect ileal contents
• Test ingredient is the only source of AA in diet
• When possible, diets were formulated to contain 20% CP
EP150
5
CIBENZA DP 100 Standardized Ileal
Digestibility Determination Using
Accepted Methods/Diets
6
CIBENZA DP 100 Standardized Ileal
Digestibility Determination Using
Accepted Methods/Diets
7
CIBENZA DP 100 Standardized Ileal
Digestibility Determination Using
Accepted Methods/Diets
Arg His Ile Leu Lys Met M+C Phe Thr Trp Val EAA
SID
, %
0
45
50
55
60
65
70
75
80
85
90
95Control
DP100
*
**
*
*
* *
**
*
*P < 0.006
Corn EAA +4.5%p
8
Gut microbiota modulation
9
How can be reduced protein-microbiota interactions?
Better gut health
Less protein fermentation in caecum
Lower amino acids assimilated by bacteria.
Higher amount of amino acids and peptides absorbed by the host
Improve digestibility of crude protein from the diet
PROTEASES
10
Bacterial 16S rRNA sequencing analysis:Species richness: total number of species within a habitat or community.Species evenness: relative contribution of each species to total number of individuals in a community.Species diversity: based on Shannon-Wiener Index (H), commonly used to characterize species diversity in a community:accounts for both richness and evenness of the species present..In
10000
20000
30000
40000
50000
60000
70000
PC NC NC+CibenzaEP150
Species richness
Internal Novus Research, B06IJE015018
P-value 0.0557
SEM 5.658
Cibenza EP150 modifies the intestinal
microbiota
a
a,b
b
PC NC NC+Cibenza EP150
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
PC NC NC+CibenzaEP150
Species eveness
P-value 0.0255
SEM 0.07
b
b
a
0
0.5
1
1.5
2
2.5
3
PC NC NC+CibenzaEP150
Species diversity
b
b
a
P-value 0.0190
SEM 0.295
total number of species
Gut microbiota
11
b
a
bb
0
1
2
3
4
5
Normal CP High CP
Ileal Clostridium perfringens count in the digesta of 15 day-old broilers
Control Protease
Cibenza EP150 reduces the development of Clostridium perfringens
• 228 Ross broilers• floor pen, 2x2 factorial design• 9 replicate pens of 8 birds each, • 0-29 days of age, • all diets based on 20% rye and 25%
wheat (model subclinical enteritis)• coccidia challenge at day 7 : 3x vacc.dose
high protein diet with poultry by product meal.
Source of variation p-value
protein level 0.128
Cibenza EP150 0.107
protein x Cibenza EP150 0.043
Log cfu
Yan. et al, WPC 2012
Cibenza EP150
(22.12%) (30%)
Gut microbiota
12
1,018 1,016984
798
600
650
700
750
800
850
900
950
1000
1050
Low CP High CP
Serum α-1-acid glycoprotein concentration day 22
Control Protease
Cibenza EP150 reduces inflammatory response
Yan et al., WPC 2012
Source of variation P-value
Protein level 0.72
Cibenza EP150 0.022
CP x Protease 0.74
Lower α-1-acid glycoprotein
Less gut imflamation
µg /ml
Cibenza EP150
Novus R&D 106IJD010011
(22.12%) (30%)
Gut microbiota
13
CIBENZA EP150 TRIALS
1. Laying hens
2. Broilers
14
Layers. Trial 1. Experimental Design
• Design
– Control vs. EP150 500 g/ton (6,792 birds)
• Treatments used
– Reduce 7.5% Crude Protein and Amino Acid
• Record
– Percentage of Egg production, Crack egg, White shell egg,
Feed intake, FCR, Egg mass
• Age: 45 week
• Date Start : October-November 2011 (8 week)
• Breed: H&N
15
Layers. Trial 1.
Effect of Cibenza EP150 in Laying hen diets
80.0
82.0
84.0
86.0
88.0
90.0
45 46 47 48 49 50 51 52
CIBENZA DP100
CONTROL
EGG PRODUCTION
65.00
65.10
65.20
65.30
65.40
65.50
65.60
CIBENZADP100
CONTROL
65.51 65.48
48.50
48.70
48.90
49.10
49.30
49.50
CIBENZA DP100 CONTROL
49.13
48.99
AVERAGE EGG WEIGHT EGG PER HEN
HOUSE
EP150 EP150
16
Layers. Trial 2
replaced 10% CP
5,000 hen layer pen trial, week 32 to 52
3 treatments : control, low protein (-10%), low protein plus EP150
Anderson et al, 2007
3632
96
94
92
90
40
a
b
a
ab
aa
ba
ab
a
98
4844 52
-10% CP -10% CP + EP150 Control
weeks
Eg
g p
rod
ucti
on
%
Trial sta
rts
17
One of the 3 largest egg producers in RU (3.5 Mio Layers, 900 Mio
eggs/y)
Objective
feed cost reduction program with Cibenza EP150
Protocol
Start: week 35; 52 000 birds in control and treatment groups
2,5% matrix use for two weeks, 5% matrix next two weeks and 7,5% matrix for 8 weeks
Results:
Feed cost reduction: app. 7,6 €/mt
Cost of feed consumption per 1000 eggs (€): 32,73 vs31,68 (-1 €)
Amount of sellable eggs: 86,3% vs 87,9% (+1,6%)
Dirty eggs: 6,7%vs 5,4% (-1,3%)
Broken+ soft eggs: 2,5% vs 2,2% (-0,3%)
Egg shell strength, Newton: 37,4 vs 36,8 (-0,6)
Findings: the economy from feed cost reduction (only!!) during the year will be €1,1 MIO
Layers Trial 3. Borovskaya
18
4.5
6.7
2.5
4.5
5.4
2.2
1.5
2
2.5
3
3.5
4
4.5
5
5.5
6
6.5
7
Incision Dirty eggs Broken+softshell
Control Cibenza DP100
86.3
87.9
85.5
86
86.5
87
87.5
88
88.5
Sellable eggs,%
Control Cibenza DP100
Borovskaya trial
Egg quality parameters
+1.6%
Difference in non-conform eggs between
non supplemented and Cibenza EP150
fed birds%
Increase in saleable egg yield (%)
with Cibenza EP150
EP150EP150
19
Control Cibenza EP150Reduction
with EP150
Feed cost,€/t 256.4 249.3 -7.11
Feed consumption per 1000
eggs, kg127,7 127,1 -0,6
Feed consumption cost per
1000 eggs, €32,73 31,68 -1,04
Feed consumption /
total egg production
per year, mt
127 700 127 100 -600
Total annual feed
costs (based on the
overall farm egg gross
output), €
32 742 280 31 686 030 -1 056 250
Borovskaya trial
ROI effect from feed cost
reduction
20
3 treatments x 8 pens x 45 broilers
Control, Negative Control -7.5% CP & AA, Negative Control with
EP150 0.5 kg/ton
-7.5% CP
-7.5% CP + EP150
Control
ab
a
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6
35d 42d
Live weight (kg)
P<0.05
b
ab
a
a
c
b
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
35d 42d
Feed conversion ratio
P<0.05
P= 0.065
Atlanta, GA , 2011
Broilers. Trial 1
EP150 replaced 7.5% CP & AA
21
b
ab
aa a
a
2.25
2.27
2.29
2.31
2.33
2.35
2.37
2.39
2.41
2.43
2.45
Low Medium High
(Kg)
AA levels
BWG
Control
Cibenza
a
ab
bcbc
bc
c
1.80
1.85
1.90
1.95
Low Medium High
AA levels
Feed:Intake ratio
Control
Cibenza
*Dig Lys Low = 1,09; 0,98; 0,84; 0,79
Med = 1,15; 1,03; 0,88; 0,83
High = 1,21; 1,08; 0,93; 0,87
Corn/soy pelleted diets
Wang et al., 2006 JAPR
Broilers. Trial 2
EP150 replaced 10% CP & AA
Capacity of EP150 to compensate
performance losses when reducing
up to 10% CP
22
Objective field trial:
• To assess the value of CIBENZA EP150 as a nutritional tool to lower dietary costs while maintaining an optimal bird performance, in comparison to a standard feed without a protease.
• CIBENZA® EP150 is a unique feed additive containing an intrinsically heat stable protease which improves animal performance and has a favorable effect on dietary protein.
• CIBENZA EP150 usage can reduce ration costs by lowering the level of costly protein sources in the feed or optimizing the use of lower digestible, cheaper alternative sources, without sacrificing animal performance.
Broilers. Trial 3
In field trial
23
Performance results
Parameter Control CIBENZA EP150Improvement with
CIBENZA EP150
FCR 1,649 1,645 -0.4pts
No. of placement pullets 104 900 105 300
Mortality (%) 3,547 4,004*
Average slaughter age (d) 41,9 41,9
Avg LW (kg) 2,863 2,928 +2.27%
EBI (pts) 399,84 407,93 +2%
Avg. Cost/t feed € 299,05 296,93
* higher mortality in House 3 in the last week of growth, related to cardio-respiratory problems (not linked to the treatment)
• Nr of antibiotic treatments was the same in both groups• Litter quality and cleanliness of feathers were experienced to be better for the CIBENZA EP150 fed birds
2.12€/tnet
savings
24
CIBENZA EP150 FEED EXAMPLES
25
Broiler, starter feed21CP, 2900Kcal, 1,20ALys
26
Broiler, starter feed21CP, 2900Kcal, 1,20ALys
27
• Contributes to secure gut health
– Less undigested protein for proteolityc fermentation (Clostri/E.coli)
• Allow to reduce feed cost
– Reformulate with matrix evaluating impact on each ingredient
• Effect per ingredient evaluated based on animal trials
• Saving on “ME” + “CP” + “dig aa”
Practical indications for application
Incorporation 250 g / ton feed
28
Thank you for your time.
Questions?
Products not available in all countries.
NOTICE: While the information contained herein (“Information”) is presented in good faith and believed to be correct as of the date hereof, Novus International, Inc., does not
guarantee satisfactory results from reliance upon such Information, disclaims all liability for any loss or damage arising out of any use of this Information or the products to which
said Information refers and MAKES NO REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, OF MERCHANTABILITY, FITNESS FOR A PARTICULAR
PURPOSE OR OF ANY OTHER NATURE WITH RESPECT TO THE INFORMATION OR PRODUCTS, except as set forth in Novus’s standard conditions of sale. Nothing
contained herein is to be construed as a recommendation to use any product or process in conflict with any patent, and Novus International, Inc., makes no representation or
warranty, express or implied, that the use thereof will not infringe any patent.
®NOVUS and CIBENZA are trademarks of Novus International, Inc., and are registered in the United States and other countries.
TM SOLUTIONS SERVICE SUSTAINABILITY and NOVABASE are trademarks of Novus International, Inc.
© 2014 Novus International, Inc. All rights reserved.